1、1This report draws from Drug Certification of Mexico in 1997: Arguments For and AgainstResolutions of Disapproval, CRS Report 97-329, March 8, 1997, by (name redacted). For trackinglegislative action, see Mexican Drug Certification Issues: U.S. Congressional Action, 1986-1998,CRS Report 98-174 F, Ma
2、rch 6, 1998; and Mexico-U.S. Relations: Issues for the 105th Congress,CRS Issue Brief 97028, by (name redacted). Fo r details on the certification process, see NarcoticsCertification and Mexico: Questions and Answers, CRS Report 97-320 F, March 6, 1997, by(name redacted), Jonathan Sanford, and (name
3、 redacted). For details on Mexican counter-narcoticsefforts in Zedillos presidency, see Mexicos Counter-Narcotics Efforts Under Zedillo, CRSReport 98-161 F, March 4, 1998, by (name redacted). Congressional Research Service The Library of CongressCRS Report for CongressReceived through the CRS Web98-
4、272 FMarch 20, 1998Drug Certification of Mexico in 1998: Arguments For and AgainstCongressional Resolutions of Disapproval(name redacted)Specialist in Latin American AffairsForeign Affairs and National Defense DivisionSummaryThis report presents arguments for and against congressional resolutions wh
